Skip to main content

agilon health, inc.

AGL
Exchange
NYSE
Industry
Services-Misc Health & Allied Services, NEC
SEC CIK
0001831097

No open-market purchases or sales by agilon health, inc. insiders were filed in the last 90 days; 179 institutions reported holding it in 13F filings for Q2 2026, worth $1.73B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by agilon health, inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
0 filings
Insiders trading
0
Net value
$0
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for agilon health, inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for agilon health, inc.
NameTitleLast reported holdingLast filingFilings, past year
Gertsch TimothyChief Accounting Officer14,152Aug 18, 20264
Zamore DeniseChief Legal Officer66,075Aug 4, 20265
Schwaneke Jeffrey A.Chief Financial Officer138,031Jul 2, 20263
Williams Ronald ADirector149,141Jun 4, 20261
Mansukani SharadDirector56,242Jun 4, 20261
McLoughlin KarenDirector8,207Jun 4, 20261
McKenzie DianaDirector7,633Jun 4, 20261
Battaglia SilvanaDirector7,926Jun 4, 20261
Wulf John WilliamDirector16,765Jun 4, 20262
O'Rourke Timothy PatrickCEO & President320,000May 11, 20261
Venkatachaliah GirishChief Technology Officer38,236Apr 16, 20263
Shaker BenjaminChief Markets Officer122,850Apr 16, 20264
Sell StevenCEO & President862,122Apr 16, 20250
Bensley TimothyChief Financial Officer39,387Apr 17, 20240
Desai VeeralChief Strategy & Dev. Officer498,013Apr 17, 20240
Kornitzer BenjaminChief Med. & Quality Officer62,058Mar 18, 20240
CD&R Investment Associates IX, Ltd.10% Owner100,000,000IndirectMay 18, 20230
CD&R Vector Holdings, L.P.10% Owner100,000,000IndirectMay 18, 20230
Kasenchak PriscillaChief Accounting Officer7,745Apr 18, 20230
Richards ClayDirector41,214Apr 18, 20230
Sobotka GlennChief Accounting Officer5,365Sep 29, 20220
Smith Michael LDirector4,126IndirectMay 27, 20220
Gourdine Michelle ADirector18,892Apr 20, 20220
Halkias TheodoreChief Business Officer5,434Jan 3, 20220
Danieley JoanChief Administrative Officer5,434Dec 21, 20210
Dombro LisaExper. & Innovation Officer11,956Sep 15, 20210
Schnall Richard JDirector0Sep 13, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 14, 2021 (view filing)5:03 PM ETSep 14Same dayCD&R Investment Associates IX, Ltd. and 1 other10% OwnerSSale−17.9M$28.98−$518.9M−8.0%205.9M after
Sep 15, 2021 (view filing)Sep 141 dayDesai VeeralChief Strategy & Dev. OfficerSSale−121.0K$28.98−$3.51M−31.6%262.0K after
Sep 15, 2021 (view filing)Sep 141 dayDombro LisaExper. & Innovation OfficerSSale−61.5K$28.98−$1.78M−83.7%12.0K after
Sep 15, 2021 (view filing)Sep 141 dayHalkias TheodoreChief Business OfficerSSale−58.6K$28.98−$1.70M−91.5%5.43K after
Sep 15, 2021 (view filing)Sep 141 dayHalkias TheodoreChief Business OfficerSSale−100.0K$28.98−$2.90M−100.0%0 after
Sep 15, 2021 (view filing)Sep 141 dayKornitzer BenjaminChief Med. & Quality OfficerSSale−11.5K$28.98−$332.5K−67.9%5.43K after
Sep 15, 2021 (view filing)Sep 141 dayMansukani SharadDirectorSSale−156.3K$28.98−$4.53M−11.3%1.23M after
Sep 15, 2021 (view filing)Sep 141 daySell StevenCEO & PresidentSSale−100.0K$28.98−$2.90M−100.0%0 afterDuplicate filing
Sep 15, 2021 (view filing)Sep 141 dayShaker BenjaminChief Markets OfficerSSale−73.0K$28.98−$2.12M−39.1%113.6K after
Sep 15, 2021 (view filing)Sep 141 dayWulf John WilliamDirectorSSale−15.3K$28.98−$444.6K−9.4%147.3K after
Nov 4, 2021 (view filing)Nov 31 dayShaker BenjaminChief Markets OfficerSSale−300$25.00−$7.50K−0.3%113.3K after
Nov 8, 2021 (view filing)Nov 44 daysShaker BenjaminChief Markets OfficerSSale−18.6K$25.19−$467.5K−16.4%94.7K after
Nov 12, 2021 (view filing)Nov 48 daysLateSobotka GlennChief Accounting OfficerSSale−150.0K$25.19−$3.78M−97.9%3.26K after
Nov 18, 2021 (view filing)Nov 16-172 daysShaker BenjaminChief Markets OfficerSSale−9.37K$25.32−$237.2K−9.9%85.4K after2 lots
Dec 17, 2021 (view filing)Dec 15-162 daysDanieley JoanChief Administrative OfficerSSale−28.5K$22.89−$652.8K−84.0%5.43K after3 lots
Dec 21, 2021 (view filing)Dec 174 daysDanieley JoanChief Administrative OfficerSSale−21.5K$22.88−$491.4K−79.8%5.43K after2 lots
Dec 28, 2021 (view filing)Dec 23-275 daysHalkias TheodoreChief Business OfficerSSale−26.7K$27.52−$735.5K−83.1%5.43K after2 lots
Dec 30, 2021 (view filing)Dec 28-292 daysShaker BenjaminChief Markets OfficerSSale−18.7K$26.68−$499.9K−22.0%66.6K after2 lots
Jan 3, 2022 (view filing)Dec 30-31, 20214 daysHalkias TheodoreChief Business OfficerSSale−13.3K$27.54−$365.6K−71.0%5.43K after2 lots
Mar 16, 2022 (view filing)Mar 14-152 daysShaker BenjaminChief Markets OfficerSSale−161.0K$19.85−$3.20M−70.7%66.6K after4 lots
Mar 16, 2022 (view filing)Mar 151 dayWulf John WilliamDirectorSSale−30.8K$19.10−$588.4K−20.9%116.5K after2 lots
Mar 18, 2022 (view filing)Mar 162 daysShaker BenjaminChief Markets OfficerSSale−37.2K$20.20−$750.5K−35.8%66.6K after
Mar 18, 2022 (view filing)Mar 162 daysDesai VeeralChief Strategy & Dev. OfficerSSale−197.3K$20.41−$4.03M−43.0%262.0K after
Apr 11, 2022 (view filing)Apr 74 daysShaker BenjaminChief Markets OfficerSSale−2.71K$25.01−$67.7K−4.1%63.9K after
Apr 20, 2022 (view filing)Apr 18-192 daysKornitzer BenjaminChief Med. & Quality OfficerSSale−12.8K$22.39−$286.0K−54.1%10.9K afterFrom original2 lots
Apr 21, 2022 (view filing)Apr 19-202 daysDesai VeeralChief Strategy & Dev. OfficerSSale−212.7K$22.54−$4.79M−43.3%278.2K after2 lots
Apr 25, 2022 (view filing)Apr 21-224 daysDesai VeeralChief Strategy & Dev. OfficerSSale−106.4K$20.41−$2.17M−27.7%278.2K after3 lots
Apr 29, 2022 (view filing)Apr 27-282 daysKornitzer BenjaminChief Med. & Quality OfficerSSale−10.8K$18.49−$199.5K−49.9%10.9K after2 lots
May 12, 2022 (view filing)May 10-112 daysKornitzer BenjaminChief Med. & Quality OfficerSSale−10.8K$16.21−$174.9K−49.9%10.9K after3 lots
May 27, 2022 (view filing)May 252 daysSmith Michael LDirectorSSale−145.9K$19.53−$2.85M−97.2%4.13K after
Jun 1, 2022 (view filing)May 27-315 daysKornitzer BenjaminChief Med. & Quality OfficerSSale−10.8K$19.68−$212.3K−49.9%10.9K after2 lots
Jun 13, 2022 (view filing)Jun 9-104 daysKornitzer BenjaminChief Med. & Quality OfficerSSale−10.8K$20.12−$217.1K−49.9%10.9K after2 lots
Jun 24, 2022 (view filing)Jun 22-232 daysKornitzer BenjaminChief Med. & Quality OfficerSSale−10.8K$19.98−$215.6K−49.9%10.9K after2 lots
Jun 28, 2022 (view filing)Jun 244 daysDesai VeeralChief Strategy & Dev. OfficerSSale−106.4K$22.50−$2.39M−27.7%278.2K after
Jul 6, 2022 (view filing)Jul 1-55 daysKornitzer BenjaminChief Med. & Quality OfficerSSale−46.6K$22.84−$1.06M−81.1%10.9K after3 lots
Jul 11, 2022 (view filing)Jul 74 daysDesai VeeralChief Strategy & Dev. OfficerSSale−319.1K$25.00−$7.98M−53.4%278.2K after
Jul 19, 2022 (view filing)Jul 15-184 daysKornitzer BenjaminChief Med. & Quality OfficerSSale−16.2K$26.41−$427.5K−59.9%10.9K after2 lots
Jul 22, 2022 (view filing)Jul 20-212 daysShaker BenjaminChief Markets OfficerSSale−100.0K$27.05−$2.70M−78.7%27.1K after4 lots
Jul 25, 2022 (view filing)Jul 214 daysDesai VeeralChief Strategy & Dev. OfficerSSale−79.8K$27.50−$2.19M−22.3%278.2K after
Aug 8, 2022 (view filing)Aug 4-54 daysKornitzer BenjaminChief Med. & Quality OfficerSSale−16.2K$25.03−$405.1K−59.9%10.9K after2 lots
Aug 12, 2022 (view filing)5:31 PM ETAug 111 dayCD&R Investment Associates IX, Ltd. and 1 other10% OwnerSSale−11.3M$24.35−$276.1M−5.5%194.6M after
Aug 25, 2022 (view filing)Aug 23-242 daysKornitzer BenjaminChief Med. & Quality OfficerSSale−10.8K$20.70−$223.3K−49.9%10.9K after2 lots
Sep 12, 2022 (view filing)Sep 8-94 daysKornitzer BenjaminChief Med. & Quality OfficerSSale−21.6K$22.82−$492.5K−66.5%10.9K after3 lots
Sep 28, 2022 (view filing)Sep 26-272 daysKornitzer BenjaminChief Med. & Quality OfficerSSale−16.2K$22.86−$370.1K−59.9%10.9K after2 lots
Oct 5, 2022 (view filing)Oct 3-42 daysKornitzer BenjaminChief Med. & Quality OfficerSSale−16.2K$23.72−$384.0K−60.8%10.4K after2 lots
Oct 18, 2022 (view filing)Oct 14-174 daysKornitzer BenjaminChief Med. & Quality OfficerSSale−10.8K$21.79−$235.2K−50.9%10.4K after2 lots
Oct 21, 2022 (view filing)Oct 19-202 daysShaker BenjaminChief Markets OfficerSSale−50.0K$20.16−$1.01M−66.1%25.6K afterAmended4 lots
Nov 3, 2022 (view filing)Nov 1-22 daysKornitzer BenjaminChief Med. & Quality OfficerSSale−10.8K$19.78−$213.5K−50.9%10.4K after2 lots
Nov 18, 2022 (view filing)Nov 16-172 daysKornitzer BenjaminChief Med. & Quality OfficerSSale−10.8K$17.98−$194.0K−50.9%10.4K after2 lots
Nov 18, 2022 (view filing)Nov 16-172 daysShaker BenjaminChief Markets OfficerSSale−37.5K$17.73−$664.9K−59.4%25.6K after2 lots